Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045778002> ?p ?o ?g. }
- W2045778002 endingPage "765" @default.
- W2045778002 startingPage "754" @default.
- W2045778002 abstract "In our arduous efforts to develop new potent HIV-1 non-nucleoside reverse transcriptase (RT) inhibitors (NNRTIs), novel piperidine-linked [1,2,4]triazolo[1,5-a]pyrimidine derivatives were designed, synthesized and evaluated for their antiviral activities in MT-4 cell cultures. Biological results showed that all of the title compounds displayed moderate to excellent activities against wild-type (wt) HIV-1 strain (IIIB) with EC50 values ranging from 8.1 nM to 2284 nM in a cell-based assay. Among them, the most promising analog 7d possessed an EC50 value of 8.1 nM against wt HIV-1, which was much more potent than the reference drugs DDI, 3 TC, NVP and DLV. Additionally, 7d demonstrated weak activity against the double mutant HIV-1 strain (K103N + Y181C), and was more efficient than NVP in a RT inhibition assay. Besides, some measured and calculated physicochemical properties of 7d, like log P and water solubility, as well as the structure-activity relationships (SARs) analysis have been discussed in detail. Furthermore, the binding mode of the active compound 7d was rationalized by molecular simulation studies." @default.
- W2045778002 created "2016-06-24" @default.
- W2045778002 creator A5016395926 @default.
- W2045778002 creator A5016741562 @default.
- W2045778002 creator A5038319371 @default.
- W2045778002 creator A5039244938 @default.
- W2045778002 creator A5040662398 @default.
- W2045778002 creator A5053817652 @default.
- W2045778002 creator A5054111597 @default.
- W2045778002 creator A5059468550 @default.
- W2045778002 creator A5061431059 @default.
- W2045778002 creator A5067947880 @default.
- W2045778002 creator A5077294818 @default.
- W2045778002 creator A5081479819 @default.
- W2045778002 creator A5091214653 @default.
- W2045778002 date "2015-03-01" @default.
- W2045778002 modified "2023-10-14" @default.
- W2045778002 title "Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches" @default.
- W2045778002 cites W1911648303 @default.
- W2045778002 cites W1976163006 @default.
- W2045778002 cites W1976923176 @default.
- W2045778002 cites W1988356299 @default.
- W2045778002 cites W1988775904 @default.
- W2045778002 cites W1991519292 @default.
- W2045778002 cites W2001473040 @default.
- W2045778002 cites W2012187236 @default.
- W2045778002 cites W2017705973 @default.
- W2045778002 cites W2023878752 @default.
- W2045778002 cites W2027111155 @default.
- W2045778002 cites W2031081818 @default.
- W2045778002 cites W2038163403 @default.
- W2045778002 cites W2038775337 @default.
- W2045778002 cites W2044890427 @default.
- W2045778002 cites W2045043030 @default.
- W2045778002 cites W2045808418 @default.
- W2045778002 cites W2046511427 @default.
- W2045778002 cites W2049421477 @default.
- W2045778002 cites W2052002840 @default.
- W2045778002 cites W2057651242 @default.
- W2045778002 cites W2062231842 @default.
- W2045778002 cites W2063825413 @default.
- W2045778002 cites W2067125249 @default.
- W2045778002 cites W2075021895 @default.
- W2045778002 cites W2082102275 @default.
- W2045778002 cites W2103389647 @default.
- W2045778002 cites W2121517775 @default.
- W2045778002 cites W2126209235 @default.
- W2045778002 cites W2130479394 @default.
- W2045778002 cites W2138414945 @default.
- W2045778002 cites W2143223762 @default.
- W2045778002 cites W2151569835 @default.
- W2045778002 cites W2327169757 @default.
- W2045778002 cites W2918044000 @default.
- W2045778002 doi "https://doi.org/10.1016/j.ejmech.2015.01.042" @default.
- W2045778002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25626145" @default.
- W2045778002 hasPublicationYear "2015" @default.
- W2045778002 type Work @default.
- W2045778002 sameAs 2045778002 @default.
- W2045778002 citedByCount "74" @default.
- W2045778002 countsByYear W20457780022015 @default.
- W2045778002 countsByYear W20457780022016 @default.
- W2045778002 countsByYear W20457780022017 @default.
- W2045778002 countsByYear W20457780022018 @default.
- W2045778002 countsByYear W20457780022019 @default.
- W2045778002 countsByYear W20457780022020 @default.
- W2045778002 countsByYear W20457780022021 @default.
- W2045778002 countsByYear W20457780022022 @default.
- W2045778002 countsByYear W20457780022023 @default.
- W2045778002 crossrefType "journal-article" @default.
- W2045778002 hasAuthorship W2045778002A5016395926 @default.
- W2045778002 hasAuthorship W2045778002A5016741562 @default.
- W2045778002 hasAuthorship W2045778002A5038319371 @default.
- W2045778002 hasAuthorship W2045778002A5039244938 @default.
- W2045778002 hasAuthorship W2045778002A5040662398 @default.
- W2045778002 hasAuthorship W2045778002A5053817652 @default.
- W2045778002 hasAuthorship W2045778002A5054111597 @default.
- W2045778002 hasAuthorship W2045778002A5059468550 @default.
- W2045778002 hasAuthorship W2045778002A5061431059 @default.
- W2045778002 hasAuthorship W2045778002A5067947880 @default.
- W2045778002 hasAuthorship W2045778002A5077294818 @default.
- W2045778002 hasAuthorship W2045778002A5081479819 @default.
- W2045778002 hasAuthorship W2045778002A5091214653 @default.
- W2045778002 hasConcept C104317684 @default.
- W2045778002 hasConcept C156719811 @default.
- W2045778002 hasConcept C178910836 @default.
- W2045778002 hasConcept C185592680 @default.
- W2045778002 hasConcept C193042331 @default.
- W2045778002 hasConcept C202751555 @default.
- W2045778002 hasConcept C21951064 @default.
- W2045778002 hasConcept C2777351918 @default.
- W2045778002 hasConcept C2779321679 @default.
- W2045778002 hasConcept C2781462491 @default.
- W2045778002 hasConcept C55493867 @default.
- W2045778002 hasConcept C67705224 @default.
- W2045778002 hasConcept C71240020 @default.
- W2045778002 hasConcept C96529984 @default.
- W2045778002 hasConceptScore W2045778002C104317684 @default.
- W2045778002 hasConceptScore W2045778002C156719811 @default.